Addressing a population of 600 million obese people worldwide, and a further 1 billion people overweight, the highly competitive global market for minimally invasive weight loss (bariatric) devices was worth more than $137 million in 2016. Next-generation technologies, especially in the intragastric balloon area, are among the factors that will lead to a more than doubling of the market to over $290 million by 2021, equivalent to a compound annual growth rate (CAGR) of roughly 16%. So says “Minimally Invasive Weight Loss Devices Market,” a new report by analyst Chrystal Larsen from Informa's Meddevicetracker medical device analysis team.
Among the other factors driving the bariatric devices market are:
